Neurogene Inc (NGNE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
11.00 +2.03 (+22.63%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 11.00 unch (unch) 16:00 ET
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NGNE | CRDF | THRD | ||
| Company | Neurogene Inc | Cardiff Oncology Inc | Third Harmonic Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.03 | 2.38 | 3.47 | ||
| High | 11.42 | 2.56 | 3.66 | ||
| Low | 8.99 | 2.36 | 3.47 | ||
| Last | 11.00 | 2.47 | 3.64 | ||
| Change | +2.03 | +0.09 | +0.17 | ||
| % Change | +22.63% | +3.78% | +4.90% | ||
| Volume | 644,200 | 1,983,500 | 217,100 | ||
| 20-Day Average Volume | 387,825 | 1,446,395 | 348,945 | ||
| Previous Close | 8.97 | 2.38 | 3.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.31 | 3.23 | 3.51 | ||
| 20-Day Raw Stochastic | 39.24% | 6.21% | 89.47% | ||
| 20-Day Relative Strength | 41.41% | 33.16% | 42.07% | ||
| Weighted Alpha | -50.87 | -67.75 | -66.48 | ||
| Today's Opinion | 100% Sell | 24% Sell | 80% Sell | ||
| Previous Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Last Month's Opinion | 96% Sell | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.14% since 04/04/25 | -10.18% since 04/04/25 | +4.60% since 04/04/25 | ||
| Low | 6.88 on 04/08/25 | 2.36 on 04/11/25 | 3.30 on 04/07/25 | ||
| High | 11.42 on 04/11/25 | 2.87 on 04/07/25 | 3.66 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | -37.75% since 03/11/25 | -31.01% since 03/11/25 | +4.30% since 03/11/25 | ||
| Low | 6.88 on 04/08/25 | 2.36 on 04/11/25 | 3.30 on 04/07/25 | ||
| High | 18.62 on 03/12/25 | 4.42 on 03/12/25 | 3.68 on 03/27/25 | ||
| 3-Month | |||||
| %Chg | -43.82% since 01/10/25 | -31.58% since 01/10/25 | -56.41% since 01/10/25 | ||
| Low | 6.88 on 04/08/25 | 2.36 on 04/11/25 | 3.18 on 02/11/25 | ||
| High | 26.48 on 02/06/25 | 4.99 on 02/21/25 | 8.39 on 01/13/25 | ||
| 6-Month | |||||
| %Chg | -77.75% since 10/11/24 | -6.08% since 10/11/24 | -70.83% since 10/11/24 | ||
| Low | 6.88 on 04/08/25 | 2.26 on 12/06/24 | 3.18 on 02/11/25 | ||
| High | 74.49 on 11/11/24 | 5.64 on 12/17/24 | 15.50 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 164,230 | 164,314 | 164,179 | ||
| Shares Outstanding, K | 14,930 | 66,524 | 45,104 | ||
| Annual Sales | 930,000 | 680,000 | 0 | ||
| Annual Net Income | -75,140,000 | -45,430,000 | -30,820,000 | ||
| Last Quarter Sales | 0 | 150,000 | 0 | ||
| Last Quarter Net Income | -20,220,000 | -11,790,000 | 1,540,000 | ||
| 60-Month Beta | 1.46 | 1.74 | 2.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 03/24/25 | -0.21 on 02/27/25 | -0.29 on 03/27/25 | ||
| Latest Earnings Date | 05/09/25 | 05/01/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 08/06/14 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||